The UK FSA’s announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the European Commission during the summer of 2020, who have currently ‘paused’ novel food applications for CBD products, on grounds that CBD might be a narcotic. How will this affect manufacturers and retailers selling across the EU and the UK after the end of the Brexit transition period?
On 31 December 2020, the transitional period for the UK and EU to agree further arrangements due to Brexit will come to an end and new rules will come into place for businesses operating in the UK. From 1 January 2021, the UK’s Foods Standards Agency (FSA) will handle all novel food applications for the UK market (rather than via the European Commission as is the case at the time of writing).
Sativa Wellness Group is focused on developing consumer products under the core “Goodbody” brand. The Goodbody brands are available online and in a growing number of retailers across the UK, all with the commitment of “CBD you can Trust”.